|
PROBENECID INCREASES THE SERUM LEVELS OF THE DRUG
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEUROTOXICITY
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
BACTERIOSTATIC DRUGS MAY INTERFERE WITH BACTERICIDAL ACTION OF PENICILLIN
|
MAY REDUCE THE RENAL CLEARANCE OF METHOTREXATE ; ELEVATES SERUM METHOTREXATE CONCENTRATIONS RESULTING IN SEVERE HEMATOLOGICAL AND GASTROINTESTINAL TOXICITY
|
|
|